Early genetic-guided medication for underserved communities
Preemptive pharmacogenetic testing in medically underserved populations
This project offers early genetic testing to help doctors choose safer, more effective medicines for people in medically underserved communities.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11137109 on NIH RePORTER |
What this research studies
If you receive care at participating clinics, researchers will review records to see which guideline-based medications are commonly prescribed and offer preemptive pharmacogenetic testing to patients. You'll be asked to provide a sample (such as saliva or blood) so genetic results can be returned to your care team and used to guide medication choices while tracking your medication satisfaction. The team will analyze clinical, demographic, and socioeconomic factors to find who benefits most. The goal is to reduce extra visits and improve the effectiveness of lower-cost medicines often used in underserved populations.
Who could benefit from this research
Good fit: Ideal candidates are patients from medically underserved populations who take medications with existing pharmacogenetic guidelines and receive care at participating University of Florida clinics.
Not a fit: People not taking medications that have pharmacogenetic guidance or those outside the participating clinic network are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this could help personalize medication choices so you need fewer visits and get more effective, lower-cost drugs.
How similar studies have performed: Previous work in broader populations has shown benefits from pharmacogenetic-guided prescribing, but this approach is less tested in medically underserved groups.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Duarte, Julio David — University of Florida
- Study coordinator: Duarte, Julio David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.